The market for precision medicine and targeted therapies is experiencing significant growth as advancements in genomics and personalized medicine reshape the landscape of healthcare. The market is driven by the increasing understanding of the genetic basis of diseases and the development of therapies that target specific molecular alterations. Precision medicine enables more precise diagnosis, treatment selection, and monitoring of patients, leading to improved outcomes and reduced side effects. The demand for targeted therapies is rising, especially in oncology, where therapies like immunotherapy and gene therapies are revolutionizing cancer treatment. However, challenges such as high costs, limited accessibility, and the need for robust clinical evidence and regulatory approvals persist. The market for precision medicine and targeted therapies is expected to continue expanding as the field continues to advance and more tailored treatment options become available.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
